World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
91
Citations
30096
World Ranking
1037
National Ranking
562

Medicine

D-Index
92
Citations
30467
World Ranking
11328
National Ranking
5814

Joseph A. Kovacs publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Joseph A. Kovacs sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 290 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Joseph A. Kovacs D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph A. Kovacs sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 91 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Joseph A. Kovacs is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on various aspects of medicine, with a significant emphasis on epidemiology, infectious diseases, and immunology. The concentration on these subfields is evident in their prolific publications and collaborative projects.

Key topics in Kovacs's research include:

  • Pneumocystis jirovecii pneumonia detection and treatment
  • Tuberculosis research and epidemiology
  • Pneumonia and respiratory infections
  • HIV/AIDS drug development and treatment
  • Immunodeficiency and autoimmune disorders
  • SARS-CoV-2 and COVID-19 research
  • COVID-19 clinical research studies

Kovacs has contributed to several recent scientific papers, including:

  • "Genomic insights into the host specific adaptation of the Pneumocystis genus," published in 2021 in Communications Biology
  • "Diversity and Complexity of the Large Surface Protein Family in the Compacted Genomes of Multiple Pneumocystis Species," published in 2020 in mBio
  • "Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States," published in 2021 in Clinical Infectious Diseases
  • "Humans Are Selectively Exposed to Pneumocystis jirovecii," published in 2020 in mBio
  • "Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections," published in 2023 in The Journal of Infectious Diseases

Frequent coauthors working with Kovacs include:

  • Liang Ma
  • Ousmane H. Cissé
  • Yueqin Liu
  • Christiane Weissenbacher-Lang
  • Melanie T. Cushion

Kovacs's work has appeared repeatedly in several scientific journals, including:

  • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (7 publications)
  • The Journal of Infectious Diseases (4 publications)
  • Journal of Fungi (4 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (4 publications)
  • The Journal of Immunology (4 publications)

Their scientific output encompasses 88 publications in the field of medicine, with 46 concentrating specifically on epidemiology and 38 on infectious diseases. Kovacs's presence in subfields such as organic chemistry and neurology further illustrates a multidisciplinary approach to medical research.

Best Publications

  • The cardiovascular response of normal humans to the administration of endotoxin

    Anthony F. Suffredini;Robert E. Fromm;Margaret M. Parker;Matthew Brenner

  • Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

    Joseph A. Kovacs;John W. Hiemenz;Abe M. Macher;Diane Stover

  • HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

    Richard T. Davey;Niranjan Bhat;Christian Yoder;Tae Wook Chun

  • Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the Fungi

    Jeffrey C. Edman;Joseph A. Kovacs;Henry Masur;Daniel V. Santi

  • Cryptococcosis in the acquired immunodeficiency syndrome.

    Joseph A. Kovacs;Andrea A. Kovacs;Michael Polis;W. Craig Wright

  • CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

    H Masur;F P Ognibene;R Yarchoan;J H Shelhamer

  • Persistence of HIV in Gut-Associated Lymphoid Tissue despite Long-Term Antiretroviral Therapy

    Tae Wook Chun;David C. Nickle;Jesse S. Justement;Jennifer H. Meyers

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.

    M Connors;J A Kovacs;S Krevat;J C Gea-Banacloche

  • USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

    David Lanier;Neil Schram;Ellen Cooper;Kenneth A. Freedberg

  • Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.

    Joseph A. Kovacs;Susan Vogel;Jeffrey M. Albert;Judith Falloon

  • Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

    J A Kovacs;M Baseler;R J Dewar;S Vogel

  • Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies

    J A Kovacs;V L Ng;H Masur;G Leoung

  • Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo

    Francesco R. Simonetti;Michele D. Sobolewski;Elizabeth Fyne;Wei Shao

  • A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS

    A G Palestine;M A Polis;M D De Smet;B F Baird

  • ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia

    Frank Maldarelli;Sarah Palmer;Martin S King;Ann Wiegand

  • Anti-retroviral effects of interferon-α in AIDS associated Kaposi's sarcoma

    H Clifford Lane;Judith Feinberg;Victoria Davey;Lawrence Deyton

  • Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection

    Joseph A. Kovacs;Henry Masur

  • Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

    Robert E. Walker;Christine M. Bechtel;Ven Natarajan;Michael Baseler

  • Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

    H. Clifford Lane;Victoria Davey;Joseph A. Kovacs;Judith Feinberg

  • Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.

    C J Allegra;B A Chabner;C U Tuazon;D Ogata-Arakaki

Frequent Co-Authors

Henry Masur
Henry Masur National Institutes of Health
H. Clifford Lane
H. Clifford Lane National Institute of Allergy and Infectious Diseases
Richard T. Davey
Richard T. Davey National Institute of Allergy and Infectious Diseases
Michael A. Polis
Michael A. Polis National Institute of Allergy and Infectious Diseases
Julia A. Metcalf
Julia A. Metcalf National Institute of Allergy and Infectious Diseases
Michael Baseler
Michael Baseler Leidos (United States)
Irini Sereti
Irini Sereti National Institutes of Health
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Vee J. Gill
Vee J. Gill National Institutes of Health
Joseph E. Parrillo
Joseph E. Parrillo Hackensack University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Nursing degrees with a focus on advanced practice, such as those for nurse practitioners, are a popular choice. Many professionals look for the which nurse practitioner program is easiest to balance rigorous study with personal commitments.

Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are another relevant option for those keen on mental health linked to immunological sciences. Recognizing programs with strong clinical experiences, such as the top online pmhnp programs, can significantly enhance practical skills and job readiness.

Cost is a critical factor when choosing a program. Students seeking affordability might consider the cheapest psych np programs without compromising educational quality. This ensures access to quality education within financial means.

Upon graduation, salaries vary widely by specialty and location. Those pursuing a Doctor of Nursing Practice (DNP) degree should review the dnp salary by specialty to understand potential earnings and make informed career decisions.

Best Scientists Citing Joseph A. Kovacs

Trending Scientists

Recently Published Articles